CN103619240B - 用于确定hrv和rrv并且用来识别潜在病症发作的方法和*** - Google Patents
用于确定hrv和rrv并且用来识别潜在病症发作的方法和*** Download PDFInfo
- Publication number
- CN103619240B CN103619240B CN201280022727.9A CN201280022727A CN103619240B CN 103619240 B CN103619240 B CN 103619240B CN 201280022727 A CN201280022727 A CN 201280022727A CN 103619240 B CN103619240 B CN 103619240B
- Authority
- CN
- China
- Prior art keywords
- data
- patient
- value
- hrv
- analysis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 201000010099 disease Diseases 0.000 title claims abstract description 73
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title claims abstract description 73
- 238000000034 method Methods 0.000 title abstract description 147
- 238000004458 analytical method Methods 0.000 claims abstract description 95
- 206010040047 Sepsis Diseases 0.000 claims abstract description 37
- 230000029058 respiratory gaseous exchange Effects 0.000 claims abstract description 37
- 208000013223 septicemia Diseases 0.000 claims abstract description 33
- 239000003814 drug Substances 0.000 claims description 46
- 229940079593 drug Drugs 0.000 claims description 37
- 238000012544 monitoring process Methods 0.000 claims description 20
- 238000007405 data analysis Methods 0.000 claims description 12
- 238000002347 injection Methods 0.000 claims description 10
- 239000007924 injection Substances 0.000 claims description 10
- 238000012806 monitoring device Methods 0.000 claims description 10
- 229920006395 saturated elastomer Polymers 0.000 claims description 2
- 230000005540 biological transmission Effects 0.000 claims 1
- 239000000835 fiber Substances 0.000 claims 1
- 230000002123 temporal effect Effects 0.000 abstract description 16
- 238000013480 data collection Methods 0.000 abstract description 14
- 230000008859 change Effects 0.000 abstract description 10
- 238000011160 research Methods 0.000 description 16
- 230000008901 benefit Effects 0.000 description 14
- 230000002980 postoperative effect Effects 0.000 description 13
- 230000036541 health Effects 0.000 description 12
- 230000006399 behavior Effects 0.000 description 11
- 230000000694 effects Effects 0.000 description 11
- 238000004422 calculation algorithm Methods 0.000 description 8
- 230000006870 function Effects 0.000 description 8
- 238000005259 measurement Methods 0.000 description 8
- 230000008569 process Effects 0.000 description 8
- 238000003860 storage Methods 0.000 description 8
- 238000012545 processing Methods 0.000 description 7
- 238000007418 data mining Methods 0.000 description 6
- 208000015181 infectious disease Diseases 0.000 description 6
- 238000007726 management method Methods 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- 230000002028 premature Effects 0.000 description 6
- 238000005516 engineering process Methods 0.000 description 5
- 238000001356 surgical procedure Methods 0.000 description 5
- 208000006816 Neonatal Sepsis Diseases 0.000 description 4
- 238000013461 design Methods 0.000 description 4
- 238000010586 diagram Methods 0.000 description 4
- 230000010247 heart contraction Effects 0.000 description 4
- 238000012986 modification Methods 0.000 description 4
- 230000004048 modification Effects 0.000 description 4
- 210000003205 muscle Anatomy 0.000 description 4
- 230000003533 narcotic effect Effects 0.000 description 4
- 238000011084 recovery Methods 0.000 description 4
- 238000005070 sampling Methods 0.000 description 4
- 229930003347 Atropine Natural products 0.000 description 3
- RKUNBYITZUJHSG-UHFFFAOYSA-N Hyosciamin-hydrochlorid Natural products CN1C(C2)CCC1CC2OC(=O)C(CO)C1=CC=CC=C1 RKUNBYITZUJHSG-UHFFFAOYSA-N 0.000 description 3
- 230000002159 abnormal effect Effects 0.000 description 3
- 238000013459 approach Methods 0.000 description 3
- RKUNBYITZUJHSG-SPUOUPEWSA-N atropine Chemical compound O([C@H]1C[C@H]2CC[C@@H](C1)N2C)C(=O)C(CO)C1=CC=CC=C1 RKUNBYITZUJHSG-SPUOUPEWSA-N 0.000 description 3
- 229960000396 atropine Drugs 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 238000000262 chemical ionisation mass spectrometry Methods 0.000 description 3
- 238000004590 computer program Methods 0.000 description 3
- 238000013500 data storage Methods 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 238000006073 displacement reaction Methods 0.000 description 3
- 239000003193 general anesthetic agent Substances 0.000 description 3
- 230000001965 increasing effect Effects 0.000 description 3
- 239000011159 matrix material Substances 0.000 description 3
- 230000002085 persistent effect Effects 0.000 description 3
- 230000035479 physiological effects, processes and functions Effects 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- 241001269238 Data Species 0.000 description 2
- 229940035674 anesthetics Drugs 0.000 description 2
- 230000003115 biocidal effect Effects 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- OROGSEYTTFOCAN-DNJOTXNNSA-N codeine Chemical compound C([C@H]1[C@H](N(CC[C@@]112)C)C3)=C[C@H](O)[C@@H]1OC1=C2C3=CC=C1OC OROGSEYTTFOCAN-DNJOTXNNSA-N 0.000 description 2
- 238000004891 communication Methods 0.000 description 2
- 230000002596 correlated effect Effects 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 238000013399 early diagnosis Methods 0.000 description 2
- 238000002001 electrophysiology Methods 0.000 description 2
- 230000007831 electrophysiology Effects 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 238000003780 insertion Methods 0.000 description 2
- 230000037431 insertion Effects 0.000 description 2
- 230000010354 integration Effects 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- BQJCRHHNABKAKU-KBQPJGBKSA-N morphine Chemical compound O([C@H]1[C@H](C=C[C@H]23)O)C4=C5[C@@]12CCN(C)[C@@H]3CC5=CC=C4O BQJCRHHNABKAKU-KBQPJGBKSA-N 0.000 description 2
- 239000003158 myorelaxant agent Substances 0.000 description 2
- 210000000653 nervous system Anatomy 0.000 description 2
- 230000000474 nursing effect Effects 0.000 description 2
- 230000008560 physiological behavior Effects 0.000 description 2
- 230000035935 pregnancy Effects 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 230000003595 spectral effect Effects 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 206010001052 Acute respiratory distress syndrome Diseases 0.000 description 1
- 206010002091 Anaesthesia Diseases 0.000 description 1
- 208000032862 Clinical Deterioration Diseases 0.000 description 1
- 206010010356 Congenital anomaly Diseases 0.000 description 1
- 206010022840 Intraventricular haemorrhage Diseases 0.000 description 1
- 206010027336 Menstruation delayed Diseases 0.000 description 1
- UQOFGTXDASPNLL-XHNCKOQMSA-N Muscarine Chemical compound C[C@@H]1O[C@H](C[N+](C)(C)C)C[C@H]1O UQOFGTXDASPNLL-XHNCKOQMSA-N 0.000 description 1
- 206010028923 Neonatal asphyxia Diseases 0.000 description 1
- 208000037212 Neonatal hypoxic and ischemic brain injury Diseases 0.000 description 1
- 208000006399 Premature Obstetric Labor Diseases 0.000 description 1
- 206010036600 Premature labour Diseases 0.000 description 1
- 208000013616 Respiratory Distress Syndrome Diseases 0.000 description 1
- 206010040049 Sepsis neonatal Diseases 0.000 description 1
- 235000003407 Sigesbeckia orientalis Nutrition 0.000 description 1
- 240000003801 Sigesbeckia orientalis Species 0.000 description 1
- 208000004301 Sinus Arrhythmia Diseases 0.000 description 1
- 101000870046 Sus scrofa Glutamate dehydrogenase 1, mitochondrial Proteins 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 230000003444 anaesthetic effect Effects 0.000 description 1
- 239000005557 antagonist Substances 0.000 description 1
- 239000002249 anxiolytic agent Substances 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000002567 autonomic effect Effects 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 208000037815 bloodstream infection Diseases 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 238000003759 clinical diagnosis Methods 0.000 description 1
- 229960004126 codeine Drugs 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 238000000205 computational method Methods 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 238000013481 data capture Methods 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- OWZREIFADZCYQD-NSHGMRRFSA-N deltamethrin Chemical compound CC1(C)[C@@H](C=C(Br)Br)[C@H]1C(=O)O[C@H](C#N)C1=CC=CC(OC=2C=CC=CC=2)=C1 OWZREIFADZCYQD-NSHGMRRFSA-N 0.000 description 1
- 238000009795 derivation Methods 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 230000003292 diminished effect Effects 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 230000005611 electricity Effects 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 238000007667 floating Methods 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- OROGSEYTTFOCAN-UHFFFAOYSA-N hydrocodone Natural products C1C(N(CCC234)C)C2C=CC(O)C3OC2=C4C1=CC=C2OC OROGSEYTTFOCAN-UHFFFAOYSA-N 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 238000009533 lab test Methods 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 238000007477 logistic regression Methods 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 230000005055 memory storage Effects 0.000 description 1
- 230000000116 mitigating effect Effects 0.000 description 1
- 229960005181 morphine Drugs 0.000 description 1
- 230000004899 motility Effects 0.000 description 1
- 238000010606 normalization Methods 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 230000000661 pacemaking effect Effects 0.000 description 1
- 230000001734 parasympathetic effect Effects 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 208000033300 perinatal asphyxia Diseases 0.000 description 1
- 230000000737 periodic effect Effects 0.000 description 1
- 230000002688 persistence Effects 0.000 description 1
- 230000006461 physiological response Effects 0.000 description 1
- 208000026440 premature labor Diseases 0.000 description 1
- 238000010223 real-time analysis Methods 0.000 description 1
- 238000011897 real-time detection Methods 0.000 description 1
- 238000007670 refining Methods 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 238000012502 risk assessment Methods 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000012549 training Methods 0.000 description 1
- 230000001052 transient effect Effects 0.000 description 1
- 238000012384 transportation and delivery Methods 0.000 description 1
- 210000001186 vagus nerve Anatomy 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
- A61B5/7271—Specific aspects of physiological measurement analysis
- A61B5/7282—Event detection, e.g. detecting unique waveforms indicative of a medical condition
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
- A61B5/0205—Simultaneously evaluating both cardiovascular conditions and different types of body conditions, e.g. heart and respiratory condition
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/0002—Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network
- A61B5/0015—Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network characterised by features of the telemetry system
- A61B5/0022—Monitoring a patient using a global network, e.g. telephone networks, internet
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/24—Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
- A61B5/316—Modalities, i.e. specific diagnostic methods
- A61B5/318—Heart-related electrical modalities, e.g. electrocardiography [ECG]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/48—Other medical applications
- A61B5/4836—Diagnosis combined with treatment in closed-loop systems or methods
- A61B5/4839—Diagnosis combined with treatment in closed-loop systems or methods combined with drug delivery
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/48—Other medical applications
- A61B5/4848—Monitoring or testing the effects of treatment, e.g. of medication
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/20—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
- A61B5/024—Detecting, measuring or recording pulse rate or heart rate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/08—Detecting, measuring or recording devices for evaluating the respiratory organs
- A61B5/0816—Measuring devices for examining respiratory frequency
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Biomedical Technology (AREA)
- Medical Informatics (AREA)
- General Health & Medical Sciences (AREA)
- Pathology (AREA)
- Animal Behavior & Ethology (AREA)
- Heart & Thoracic Surgery (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Surgery (AREA)
- Physics & Mathematics (AREA)
- Veterinary Medicine (AREA)
- Physiology (AREA)
- Cardiology (AREA)
- Pulmonology (AREA)
- Computer Vision & Pattern Recognition (AREA)
- Psychiatry (AREA)
- Signal Processing (AREA)
- Artificial Intelligence (AREA)
- Computer Networks & Wireless Communication (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Primary Health Care (AREA)
- Databases & Information Systems (AREA)
- Data Mining & Analysis (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring And Recording Apparatus For Diagnosis (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
Claims (11)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201161453905P | 2011-03-17 | 2011-03-17 | |
US61/453,905 | 2011-03-17 | ||
PCT/CA2012/000243 WO2012122637A1 (en) | 2011-03-17 | 2012-03-19 | Method and system for determining hrv and rrv and use to identify potential condition onset |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103619240A CN103619240A (zh) | 2014-03-05 |
CN103619240B true CN103619240B (zh) | 2017-03-01 |
Family
ID=46829987
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201280022727.9A Active CN103619240B (zh) | 2011-03-17 | 2012-03-19 | 用于确定hrv和rrv并且用来识别潜在病症发作的方法和*** |
Country Status (6)
Country | Link |
---|---|
US (1) | US9730645B2 (zh) |
CN (1) | CN103619240B (zh) |
AU (1) | AU2012228898B2 (zh) |
CA (1) | CA2866969C (zh) |
GB (1) | GB2503401B (zh) |
WO (1) | WO2012122637A1 (zh) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050288571A1 (en) * | 2002-08-20 | 2005-12-29 | Welch Allyn, Inc. | Mobile medical workstation |
CN106132297B (zh) | 2013-12-13 | 2019-11-26 | 昆腾医疗公司 | 用于在对象中测定全身性炎症的指标的装置 |
JP2016047093A (ja) * | 2014-08-27 | 2016-04-07 | セイコーエプソン株式会社 | 生体情報解析システム、生体情報処理システム及び生体情報解析装置 |
WO2016061513A1 (en) * | 2014-10-16 | 2016-04-21 | The Arizona Board Of Regents Of Behalf Of The University Of Arizona | Real-time vagal monitoring and intervention |
US9456014B2 (en) * | 2014-12-23 | 2016-09-27 | Teradata Us, Inc. | Dynamic workload balancing for real-time stream data analytics |
US9936919B2 (en) * | 2015-09-25 | 2018-04-10 | Intel Corporation | Devices, systems, and methods for determining heart rate of a subject from noisy electrocardiogram data |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050197865A1 (en) * | 2004-03-05 | 2005-09-08 | Desmond Jordan | Physiologic inference monitor |
WO2009043144A1 (en) * | 2007-10-03 | 2009-04-09 | Ottawa Health Research Institute | Method and apparatus for monitoring physiological parameter variability over time for one or more organs |
WO2011009211A1 (en) | 2009-07-22 | 2011-01-27 | Carolyn Patricia Mcgregor | System, method and computer program for multi-dimensional temporal data mining |
-
2012
- 2012-03-19 CN CN201280022727.9A patent/CN103619240B/zh active Active
- 2012-03-19 GB GB1318320.7A patent/GB2503401B/en active Active
- 2012-03-19 AU AU2012228898A patent/AU2012228898B2/en active Active
- 2012-03-19 WO PCT/CA2012/000243 patent/WO2012122637A1/en active Application Filing
- 2012-03-19 US US14/005,107 patent/US9730645B2/en active Active
- 2012-03-19 CA CA2866969A patent/CA2866969C/en active Active
Non-Patent Citations (1)
Title |
---|
多维时间抽象化结构和其在支持新生儿重症监护中的应用;Michael Stacey等;《第29届IEEE医学生物学国际年会学报》;20070826;正文第3752-3756页,摘要 * |
Also Published As
Publication number | Publication date |
---|---|
AU2012228898B2 (en) | 2016-05-12 |
AU2012228898A1 (en) | 2013-10-31 |
GB201318320D0 (en) | 2013-11-27 |
CA2866969C (en) | 2021-04-27 |
US9730645B2 (en) | 2017-08-15 |
US20140052007A1 (en) | 2014-02-20 |
GB2503401A (en) | 2013-12-25 |
WO2012122637A1 (en) | 2012-09-20 |
GB2503401B (en) | 2017-01-25 |
CN103619240A (zh) | 2014-03-05 |
CA2866969A1 (en) | 2012-09-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Tjepkema-Cloostermans et al. | Outcome prediction in postanoxic coma with deep learning | |
Mohktar et al. | Predicting the risk of exacerbation in patients with chronic obstructive pulmonary disease using home telehealth measurement data | |
Pathinarupothi et al. | Instantaneous heart rate as a robust feature for sleep apnea severity detection using deep learning | |
CN103619240B (zh) | 用于确定hrv和rrv并且用来识别潜在病症发作的方法和*** | |
US10265029B2 (en) | Methods and systems for calculating and using statistical models to predict medical events | |
CN102014742B (zh) | 现场可部署的震荡检测器 | |
Boursalie et al. | M4CVD: Mobile machine learning model for monitoring cardiovascular disease | |
Wu et al. | Modeling perceived stress via HRV and accelerometer sensor streams | |
McGregor et al. | Variability analysis with analytics applied to physiological data streams from the neonatal intensive care unit | |
CN101939738A (zh) | 用于监控一个或多个器官的随着时间过去的生理参数变异性的方法和装置 | |
KR20090024808A (ko) | 치매 및 치매성 장애의 평가 | |
McDonald et al. | The real-time fMRI neurofeedback based stratification of Default Network Regulation Neuroimaging data repository | |
CN104903897A (zh) | 癫痫和癫痫发作的易发性的评定 | |
CN104115144A (zh) | 用于多维时域和相关数据挖掘框架、分析和子分组的***、方法和计算机程序 | |
Nagaraj et al. | Automatic classification of sedation levels in ICU patients using heart rate variability | |
Khan et al. | Agitation detection in people living with dementia using multimodal sensors | |
Tazarv et al. | Personalized stress monitoring using wearable sensors in everyday settings | |
CN109715049A (zh) | 用于创伤性脑损伤的多模态生理刺激和评估的协议和签名 | |
Kalkstein et al. | Using machine learning to detect problems in ECG data collection | |
Zhang et al. | Auto-annotating sleep stages based on polysomnographic data | |
Lee et al. | Phenotypes of engagement with mobile health technology for heart rhythm monitoring | |
KR102169637B1 (ko) | 사망 위험도의 예측 방법 및 이를 이용한 사망 위험도의 예측 디바이스 | |
Kyrollos et al. | Detection of false alarms in the NICU using pressure sensitive mat | |
Blount et al. | On the integration of an artifact system and a real-time healthcare analytics system | |
CN110710956A (zh) | 一种昏迷患者的预后评估方法和评估*** |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB03 | Change of inventor or designer information | ||
CB03 | Change of inventor or designer information |
Inventor after: Mcgregor Carolyn Patricia Inventor after: CATLEY CHRISTINA ANNE Inventor before: Mcgregor Carolyn Patricia Inventor before: CATLEY CHRISTINA ANNE Inventor before: JAMES ANDREW GIBSON |
|
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TA01 | Transfer of patent application right | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20170207 Address after: Ontario, Canada Applicant after: Mcgregor Carolyn Patricia Applicant after: CATLEY CHRISTINA ANNE Address before: Ontario, Canada Applicant before: Mcgregor Carolyn Patricia Applicant before: CATLEY CHRISTINA ANNE Applicant before: JAMES ANDREW GIBSON |